Back to all programs Open

Non-Small Cell Lung Cancer

Up to $4,000 available in assistance for Private/Uninsured & Public

Check Eligibility & Apply for Non-Small Cell Lung Cancer (opens in a new tab)

Non-Small Cell Lung Cancer - Privately Insured

Open
Check Eligibility & Apply for Non-Small Cell Lung Cancer - Privately Insured (opens in a new tab)

Privately insured programs are designed for individuals with Group, COBRA, Individual, or Marketplace insurance, or are uninsured.

Am I likely eligible?

This is a guide, not a decision. Checking your eligibility takes a few questions and gives you an answer.

What assistance is available?

$4,000 total assistance available, shared across all types below

Uninsured

  • Copay
  • Medical Expenses
  • Travel Expense up to $500

Private Insurance

  • Copay
  • Medical Expenses
  • Premium
  • Travel Expense up to $500

Resources

These organizations offer information and support for this condition. They are independent of Accessia Health, and may not currently have assistance available for this program.

Non-Small Cell Lung Cancer - Publicly Insured

At Capacity — Waitlist Open
Join Waitlist for Non-Small Cell Lung Cancer - Publicly Insured (opens in a new tab)

Programs for those with public or federally sponsored insurance include all forms of Medicare, Medicaid, Tricare, or Veterans.

Am I likely eligible?

This is a guide, not a decision. Checking your eligibility takes a few questions and gives you an answer.

What assistance is available?

$4,000 total assistance available, shared across all types below

  • Copay At Capacity
  • Medical Expenses At Capacity
  • Premium At Capacity
  • Travel Expense up to $500

Resources

These organizations offer information and support for this condition. They are independent of Accessia Health, and may not currently have assistance available for this program.

About Non-Small Cell Lung Cancer

Non-small cell lung cancer (NSCLC) is any type of epithelial lung cancer other than small cell lung cancer (SCLC). There are several types of NSCLCs but the most common are squamous cell carcinoma, large cell carcinoma and adenocarcinoma. Although NSCLCs are associating with cigarette smoking, adenocarcinomas may be found in patients who never smoked.

It is estimated that there will be approximately 240,000 new cases of lung cancer this year and at least 127,000 deaths. It is the leading cause of cancer-related mortality in the United States.

Diagnosis codes

Your provider uses one of these codes when confirming your diagnosis. You do not need to know your code to apply.

  • C34 Malignant neoplasm of bronchus and lung
  • C34.0 Malignant neoplasm of main bronchus
  • C34.00 Malignant neoplasm of unspecified main bronchus
  • C34.01 Malignant neoplasm of right main bronchus
  • C34.02 Malignant neoplasm of left main bronchus
  • C34.1 Malignant neoplasm of upper lobe, bronchus or lung
  • C34.10 Malignant neoplasm of upper lobe, unspecified bronchus or lung
  • C34.11 Malignant neoplasm of upper lobe, right bronchus or lung
  • C34.12 Malignant neoplasm of upper lobe, left bronchus or lung
  • C34.2 Malignant neoplasm of middle lobe, bronchus or lung
  • C34.3 Malignant neoplasm of lower lobe, bronchus or lung
  • C34.30 Malignant neoplasm of lower lobe, unspecified bronchus or lung
  • C34.31 Malignant neoplasm of lower lobe, right bronchus or lung
  • C34.32 Malignant neoplasm of lower lobe, left bronchus or lung
  • C34.8 Malignant neoplasm of overlapping sites of bronchus and lung
  • C34.80 Malignant neoplasm of overlapping sites of unspecified bronchus and lung
  • C34.81 Malignant neoplasm of overlapping sites of right bronchus and lung
  • C34.82 Malignant neoplasm of overlapping sites of left bronchus and lung
  • C34.9 Malignant neoplasm of unspecified part of bronchus or lung
  • C34.90 Malignant neoplasm of unspecified part of unspecified bronchus or lung
  • C34.91 Malignant neoplasm of unspecified part of right bronchus or lung
  • C34.92 Malignant neoplasm of unspecified part of left bronchus or lung

Covered medications

142 medications are covered by this program. Assistance is not limited to medication costs.

  • Abraxane
  • Adagrasib
  • Adriamycin
  • Afatinib Dimaleate
  • Alecensa
  • Alectinib HCl
  • Alimta
  • Alunbrig
  • Alymsys
  • Amivantamab-Hyaluronidase-lpuj
  • Amivantamab-vmjw
  • Atezolizumab
  • Atezolizumab-Hyaluronidas-tqjs
  • Augtyro
  • Avastin
  • Avgemsi
  • Avopef
  • Axtle
  • Beizray
  • Bevacizumab
  • Bevacizumab-adcd
  • Bevacizumab-awwb
  • Bevacizumab-bvzr
  • Bevacizumab-maly
  • Bevacizumab-nwgd
  • Binimetinib
  • Bizengri (750 MG Dose)
  • Braftovi
  • Brigatinib
  • Capmatinib HCl
  • Cemiplimab-rwlc
  • Ceritinib
  • Crizotinib
  • Cyramza
  • Cytalux
  • DOCEtaxel
  • DOCEtaxel & Albumin
  • DOXOrubicin HCl
  • Dabrafenib Mesylate
  • Dacomitinib
  • Datopotamab Deruxtecan-dlnk
  • Datroway
  • Docivyx
  • Durvalumab
  • Emrelis
  • Encorafenib
  • Enhertu
  • Ensacove
  • Ensartinib HCl
  • Entrectinib
  • Erlotinib HCl
  • Etopophos
  • Etoposide
  • Etoposide Phosphate
  • Exkivity
  • Fam-Trastuzumab Deruxtec-nxki
  • Gavreto
  • Gefitinib
  • Gemcitabine HCl
  • Gemcitabine HCl-NaCl
  • Gilotrif
  • Hernexeos
  • Hycamtin
  • Hyrnuo
  • Ibtrozi
  • Imdelltra
  • Imfinzi
  • Imjudo
  • Infugem
  • Inlexzo
  • Ipilimumab
  • Iressa
  • Jobevne
  • Keytruda
  • Keytruda Qlex
  • Krazati
  • Lazcluze
  • Lazertinib Mesylate
  • Libtayo
  • Lorbrena
  • Lorlatinib
  • Lumakras
  • Lurbinectedin
  • Mekinist
  • Mektovi
  • Mobocertinib Succinate
  • Mvasi
  • Necitumumab
  • Nivolumab
  • Nivolumab-Hyaluronidase-nvhy
  • Opdivo
  • Opdivo Qvantig
  • Osimertinib Mesylate
  • PACLitaxel
  • PACLitaxel Protein-Bound Part
  • PEMEtrexed
  • PEMEtrexed Dipotassium
  • PEMEtrexed Disodium
  • PEMEtrexed Ditromethamine
  • Pafolacianine Sodium
  • Pembrolizumab
  • Pembrolizumab-Berahyalur-pmph
  • Pemfexy
  • Pemrydi RTU
  • Photofrin
  • Porfimer Sodium
  • Portrazza
  • Pralsetinib
  • Ramucirumab
  • Repotrectinib
  • Retevmo
  • Rozlytrek
  • Rybrevant
  • Rybrevant Faspro
  • Selpercatinib
  • Sevabertinib
  • Sotorasib
  • Tabrecta
  • Tafinlar
  • Tagrisso
  • Taletrectinib Adipate
  • Tarceva
  • Tarlatamab-dlle
  • Tecentriq
  • Tecentriq Hybreza
  • Telisotuzumab Vedotin-tllv
  • Tepmetko
  • Tepotinib HCl
  • Toposar
  • Topotecan HCl
  • Trametinib Dimethyl Sulfoxide
  • Tremelimumab-actl
  • Vegzelma
  • Vinorelbine Tartrate
  • Vizimpro
  • Xalkori
  • Yervoy
  • Zenocutuzumab-zbco(750MG Dose)
  • Zepzelca
  • Zirabev
  • Zongertinib
  • Zykadia

Ready to find out if you qualify?

Checking your eligibility takes a few questions and gives you an answer. If this program is at capacity you can join the waitlist and we will contact you when it reopens.

Check Eligibility & Apply (opens in a new tab)